Type 2 & other diabetes

Comparable performance of 1,5-anhydroglucitol and continuous glucose monitoring in detecting subclinical atherosclerosis in elderly patients with type 2 diabetes

Cardiovasc DiabetolPublished Cross-sectional study

Study context

Population
Adults aged ≥ 60 years with T2D
Participants
2,509 adults
Outcome
Abnormal CIMT (mean thickness ≥ 1.0 mm by high-resolution US)

Main finding

As reported in the abstract

Abnormal CIMT (mean thickness ≥ 1.0 mm)

Prevalence of abnormal carotid intima-media thickness (CIMT), all participants

44.2%

n = 1,109

Observational data: associations, not effects.

Further findings

Continuous glucose monitoring (CGM) metrics and abnormal CIMT

Time in range (TIR), mean sensor glucose (MSG) and time above range (TAR) > 10.0, but not coefficient of variation (CV) or SD, significantly associated with abnormal CIMT

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

Comparable performance of 1,5-anhydroglucitol and continuous glucose monitoring in detecting subclinical atherosclerosis in elderly patients with type 2 diabetes. Cardiovasc Diabetol. Published 21 November 2025. doi:10.1186/s12933-025-02993-1

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.